I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Autoantibodies neutralizing type I IFNs are present in ~4% ..:
Bastard P
;
Gervais A
;
Voyer T.L
...
Science Immunology. , 2021
Link:
https://doi.org/10.1126/sciimmunol.abl4340
RT Journal T1
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
UL https://suche.suub.uni-bremen.de/peid=base-ftistanbulcuniv:oai:acikerisim.iuc.edu.tr:20.500.12831_9289&Exemplar=1&LAN=DE A1 Bastard P A1 Gervais A A1 Voyer T.L A1 Rosain J A1 Philippot Q A1 Manry J A1 Michailidis E PB American Association for the Advancement of Science YR 2021 K1 alpha2 interferon K1 autoantibody K1 interferon K1 omega interferon K1 alpha interferon K1 immunoglobulin G K1 interferon omega 1 K1 neutralizing antibody K1 adolescent K1 adult K1 aged K1 antibody detection K1 Article K1 child K1 cohort analysis K1 controlled study K1 coronavirus disease 2019 K1 critically ill patient K1 disease severity K1 enzyme linked immunosorbent assay K1 fatality K1 female K1 human K1 infant K1 major clinical study K1 male K1 mortality rate K1 prevalence K1 protein blood level K1 virus neutralization K1 virus replication K1 blood K1 case control study K1 critical illness K1 immunology K1 middle aged K1 mortality K1 newborn K1 preschool child K1 very elderly K1 young adult K1 80 and over K1 Antibodies K1 Neutralizing JF Science Immunology LK http://dx.doi.org/https://doi.org/10.1126/sciimmunol.abl4340 DO https://doi.org/10.1126/sciimmunol.abl4340 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)